Mulroy Michael H.
SEC-identified person · CIK 1509725 Identifier-verified
Public-company roles (from insider filings)
| Company | Capacity as filed | Filings |
|---|---|---|
| Lineage Cell Therapeutics, Inc. LCTX | Director | filed 2014 - 2025 |
| Serina Therapeutics, Inc. SER | Director | filed 2018 - 2019 |
| Asterias Biotherapeutics, Inc. ASTY | Director · President and CEO | filed 2017 - 2019 |
| Questcor Pharmaceuticals INC QSC | Sr VP, CFO & General Counsel | filed 2011 - 2014 |
| Comarco INC cmro | Director | filed 2011 - 2013 |
All roles under one Commission-assigned identifier - the same person by the SEC's own record, not by name matching. From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.